Controlled daily peanut exposure successfully treats toddler allergies in Swedish study

A few treated children experienced severe allergic reactions requiring adrenaline injections during dose-escalation periods, though most side effects were mild.

In Stockholm, researchers at Karolinska Institutet have offered a quiet but profound reordering of what parents once accepted as permanent fate: that a child born with a peanut allergy must carry that burden for life. Through a carefully supervised process of gradual exposure beginning in toddlerhood, the immune system — still young and malleable — can be guided toward acceptance rather than alarm. The findings, published in The Lancet Regional Health – Europe, suggest that the earliest years of life may hold a window of opportunity that medicine is only beginning to understand how to open.

Controlled daily peanut exposure successfully treats toddler allergies in Swedish study

Cobertura Relacionada

Receba o Register no seu e-mail